Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
The purpose of this study is to evaluate the effectiveness, tolerability, and safety of oxymorphone immediate release (IR) oral liquid as an analgesic in pediatric subjects having severe to moderate chronic pain.
Chronic Pain
DRUG: oxymorphone IR
Change in pain intensity from baseline to last assessment using the Face, Legs, Activity, Cry, Consolability (FLACC) pain scale., weekly for 1 month during titration|Change in pain intensity from baseline to last assessment using the Face, Legs, Activity, Cry, Consolability (FLACC) pain scale., bi-weekly for three months in the maintenance phase
Safety Assessment of Adverse Events, vital signs including oxygen saturation, Blood Pressure, and Heart Rate., weekly for 1 month during titration|Safety Assessment of Adverse Events, vital signs including oxygen saturation, Blood Pressure, and Heart Rate., bi-weekly for 3 months in the maintenance phase
The purpose of this study is to evaluate the effectiveness, tolerability, and safety of oxymorphone immediate release (IR) oral liquid as an analgesic in pediatric subjects having severe to moderate chronic pain.